Goldman Sachs initiates coverage on India's Chola Investment and Finance with 'buy'
** Shares of Cholamandalam Investment and Finance CHLA.NS gain as much as 4.1%
** Goldman Sachs starts coverage with "buy" and PT of 1,786 rupees, an upside of 20.1% to last close
** Expects co to improve ROA profile and a robust loan growth over FY24-FY27, driven by capacity to diversify loan books for new businesses, secured nature of its book, operating leverage realization in new businesses
** Forecasts EPS growth of 33% CAGR over FY24-27
** Says its EPS estimates for FY25-26 are ahead of visible alpha consensus due to higher net interest income and lower operating costs
** On avg, analysts rate stock is "buy", with median PT of 1,535 rupees vs current trading price of 1,549 rupees - LSEG
** CHLA has risen 21.6% YTD
Reporting by Meenakshi Maidas in Bengaluru
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
